Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- 8-K Current report
- 3.1 EX-3.1
- 3.2 EX-3.2
- 10.1 EX-10.1
- 10.2 EX-10.2
- 10.3 EX-10.3
- 10.4 EX-10.4
- 10.5 EX-10.5
- 10.6 EX-10.6
- 16.1 EX-16.1
- 21.1 EX-21.1
- 99.1 Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets; Unregistered Sales of Equity Securities; Changes in Registrant's Certifying Accountant; Changes in Control of Registrant; Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Change in Shell Company Status; Financial Statements and Exhibits
- Download Excel data file
- View Excel data file
SABS similar filings
- 22 Nov 21 Financial Statements and Exhibits
- 22 Nov 21 SAB Biotherapeutics Reports Third Quarter 2021 Financial Results and Provides Company Update
- 19 Nov 21 Entry into a Material Definitive Agreement
- 28 Oct 21 Entry into a Material Definitive Agreement
- 21 Oct 21 Submission of Matters to a Vote of Security Holders
- 13 Oct 21 Other Events
- 12 Oct 21 Entry into a Material Definitive Agreement
Filing view
External links
Exhibit 10.2